← Grupo Cibest S.A.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Net income | $4.4b | $1.9b | $3.4b | ($1.6b) | $2.8b | $9.4b | $7.9b | $6.2t | $6.4t | $3.9t | |
| Net income for the year | — | — | — | ($1.6b) | $2.8b | $9.4b | $7.9b | — | — | — | |
| Depreciation and amortization | $1.4b | $1.5b | $1.1b | $1.1b | $1.5b | $1.2b | $1.1b | $1.1t | $1.0t | $1.1t | |
| Other assets impairment | — | — | — | — | — | — | — | $42.0b | $106.4b | $58.0b | |
| (Recovery) / impairment of investments in subsidiaries, associates and joint ventures | — | — | — | — | — | — | — | $108.2b | $314.3b | ($117.9b) | |
| Impairment of goodwill | — | — | — | — | — | — | — | $0 | $0 | $3.5t | |
| Credit impairment charges on loans and advances and financial leases | — | — | — | — | — | — | — | $7.5t | $5.4t | $4.6t | |
| Credit impairment charges on off balance sheet credit and other financial instruments | — | — | — | — | — | — | — | $107.0m | $38.7b | ($29.6b) | |
| Equity method | — | — | — | — | — | — | — | ($113.1b) | ($222.6b) | ($349.0b) | |
| Interest expense from financing activities | $40.2m | $54.4m | $16.5m | $55.0m | $53.7m | $87.4m | $56.4m | $153.7m | $3.7m | — | |
| Interest expense | — | ($54.4m) | ($16.5m) | ($55.0m) | ($53.7m) | ($87.4m) | ($56.4m) | ($153.7m) | ($3.7m) | — | |
| Gain on sales of assets | — | — | — | — | — | — | — | ($170.9b) | ($103.5b) | ($238.3b) | |
| Valuation gain on investment securities | — | — | — | — | — | — | — | ($1.7t) | ($2.4t) | ($2.5t) | |
| Gain upon disposal of investment in subsidiaries, associates, and joint ventures | — | — | — | — | — | — | — | $0 | $0 | ($11.5b) | |
| Valuation on derivative financial instruments | — | — | — | — | — | — | — | ($180.2b) | ($323.8b) | $62.5b | |
| Income tax | $936.4m | $1.1b | $752.5m | $3.3b | $2.1b | $4.4b | $3.3b | $1.9t | $2.4t | $2.9t | |
| Bonuses and short-term benefits | $6.4m | ($8.0m) | ($10.1m) | $41.6m | $12.1m | $979k | $6.5m | $734.9b | $811.6b | $1.0t | |
| Investment property valuation | — | — | — | — | — | — | — | ($197.5b) | ($200.3b) | ($109.8b) | |
| Other non-cash items | — | — | — | — | — | — | — | $74.9b | ($10.3b) | ($41.4b) | |
| Net interest | ($140.0m) | ($252.3m) | ($312.8m) | ($146.0m) | ($107.8m) | ($65.9m) | ($445.9m) | ($18.6t) | ($17.6t) | ($18.0t) | |
| Decrease / (increase) in derivative financial instruments | — | — | — | — | — | — | — | $860.0b | ($394.6b) | $290.1b | |
| Decrease / (increase) in accounts receivable | ($209.5m) | ($1.2b) | ($1.1b) | $515.7m | ($795.7m) | ($1.8b) | ($440.4m) | ($525.5b) | ($713.1b) | $1.2t | |
| Increase in loans and advances to customers | — | — | — | — | — | — | — | ($10.6t) | ($21.6t) | ($27.3t) | |
| (Increase) / decrease in other assets | — | — | — | — | — | — | — | ($1.2t) | $895.9b | ($1.2t) | |
| Increase / (decrease) in accounts payable | ($372.4m) | $1.2b | $460.4m | ($152.0m) | $1.1b | $836.4m | $2.4b | $945.9b | ($859.4b) | $742.0b | |
| Increase / (decrease) in other liabilities | — | — | — | — | — | — | — | $245.6b | ($1.4t) | $409.4b | |
| Increase in deposits by customers | — | — | — | — | — | — | — | $17.0t | $18.3t | $28.0t | |
| Increase / (decrease) in estimated liabilities and provisions | — | — | — | — | — | — | — | ($40.6b) | ($18.2b) | $8.5b | |
| Net changes in investment securities recognized at fair value through profit or loss | — | — | — | — | — | — | — | ($2.0t) | ($8.4t) | ($3.0t) | |
| Proceeds from sales of assets held for sale and inventories | — | — | — | — | — | — | — | $1.1t | $1.4t | $1.5t | |
| Recovery of charged-off loans | — | — | — | — | — | — | — | $770.9b | $926.3b | $865.9b | |
| Interest received | — | — | — | — | — | — | — | $34.7t | $33.2t | $31.8t | |
| Purchases of debt instruments at amortized cost | — | — | — | — | — | — | — | ($3.6t) | ($2.1t) | ($2.0t) | |
| Purchases of debt instruments at fair value through OCI | — | — | — | — | — | — | — | ($7.8t) | ($448.9b) | ($436.3b) | |
| Purchases of equity instruments at fair value through OCI and interests in associates and joint ventures | — | — | — | — | — | — | — | ($122.9b) | ($134.4b) | ($21.5b) | |
| Proceeds from equity instruments at fair value through OCI and interests in associates and joint ventures | — | — | — | — | — | — | — | $16.8b | $40.5b | $77.3b | |
| Purchase of other long-term assets | — | — | — | — | — | — | — | ($351.5b) | ($203.1b) | ($275.1b) | |
| Increase in repurchase agreements and other similar secured borrowing | — | — | — | — | — | — | — | $304.8b | $550.6b | $34.0b | |
| Proceeds from borrowings from other financial institutions | — | — | — | — | — | — | — | $9.9t | $9.4t | $7.5t | |
| Repayment of borrowings from other financial institutions | — | — | — | — | — | — | — | ($9.9t) | ($10.5t) | ($10.8t) | |
| Payment of lease liability | — | — | — | — | — | — | — | ($182.6b) | ($174.8b) | ($203.4b) | |
| Buyback of shares | — | — | — | — | — | — | — | $0 | $0 | ($431.4b) | |
| Transactions with non-controlling interests | — | — | — | — | — | — | — | ($41.2b) | ($19.5b) | ($18.1b) | |
| (Gain) Loss in financial instruments | — | — | — | — | — | $0 | $778.6m | ($64.4m) | ($68.1m) | — | |
| Decrease (Increase) in Related parties’ receivables | ($172.3m) | ($41.3m) | $17.5m | ($58.5m) | $98.9m | ($78.9m) | ($69.5m) | ($68.2m) | ($102.4m) | — | |
| Decrease (Increase) in Inventory | ($84.9m) | ($887.6m) | ($1.1b) | $1.8b | ($777.4m) | ($2.7b) | ($1.5b) | $1.6b | $357.6m | — | |
| Increase (Decrease) in Related parties’ payables | ($36.1m) | $39.6m | $90.8m | ($93.1m) | ($113.2m) | ($38.6m) | ($8.5m) | $62.8m | $685.1m | — | |
| Increase (Decrease) in Accounts payable other and accrued liabilities and taxes other than income taxes | — | — | — | — | — | ($2.8b) | ($3.8b) | ($2.0b) | ($2.3b) | — | |
| Decrease (increase) in other non-current assets | ($119.5m) | ($60.1m) | $159.7m | ($52.3m) | $10.7m | ($9.2m) | ($32.8m) | $301.9m | $162.3m | — | |
| Acquisition of other equity instruments | — | — | — | — | — | $0 | ($2.1b) | ($88.6m) | $0 | — | |
| Gain (Loss) on financial instruments | — | — | — | — | — | $0 | ($778.6m) | $64.4m | $68.1m | — | |
| Interest income collected | $108.2m | $54.2m | $102.3m | $146.0m | $107.8m | $65.9m | $445.9m | $931.9m | $1.6b | — | |
| Loan from related parties | — | — | — | — | — | $0 | $2.4b | $0 | $0 | — | |
| Repurchase and placement of own capital stocks, net | $938.3m | ($278.9m) | ($1.6b) | ($156.1m) | ($42.0m) | ($74.5m) | ($90.1m) | ($89.0m) | ($126.5m) | — | |
| (Decrease) in Accounts payable other and accrued liabilities and taxes other than income taxes | $410.1m | $800.1m | $929.8m | $484.1m | ($404.1m) | ($2.8b) | ($3.8b) | — | — | — | |
| Loss on financial instruments | — | — | — | — | — | — | ($778.6m) | — | — | — | |
| Allowance for doubtful accounts | ($16.5m) | $5.3m | $27.9m | $5.3m | $0 | — | — | — | — | — | |
| Unrealized foreign exchange loss (gain), net | $169.7m | ($35.8m) | ($7.0m) | $18.0m | $0 | — | — | — | — | — | |
| Collection of loans to related parties | — | — | $1.9b | $1.1b | — | — | — | — | — | — | |
| Cash paid for Business acquisition, net | — | — | ($639.0m) | — | — | — | — | — | — | — | |
| Loans granted to related parties | ($2.3b) | ($412.4m) | ($477.1m) | — | — | — | — | — | — | — | |
| Payments received on Loans from related parties | ($40.2m) | ($41.0m) | ($984.6m) | — | — | — | — | — | — | — | |
| Total Adjustments | $6.8b | $4.2b | $5.0b | $2.7b | $6.3b | $15.0b | $12.7b | $6.2b | $11.9b | — | |
| Purchases of premises and equipment and investment properties | ($3.1b) | ($3.0b) | ($2.0b) | ($1.3b) | ($951.2m) | ($1.1b) | ($1.7b) | ($2.4t) | ($2.0t) | ($2.2t) | |
| Proceeds from sales of premises and equipment and investment properties | — | — | — | — | — | — | — | $185.3b | $414.0b | $496.1b | |
| Net cash used in investing activities | ($5.4b) | ($3.1b) | ($820.2m) | ($106.7m) | ($832.7m) | ($1.0b) | ($4.1b) | ($159.7b) | ($559.2b) | ($2.2t) | |
| Net Cash from Investing Activities | ($54.1m) | $339.5m | $88.9m | — | — | — | — | — | — | — | |
| Proceeds from maturities of debt instruments at amortized cost | — | — | — | — | — | — | — | $4.7t | $1.6t | $1.1t | |
| Proceeds from debt instruments at fair value through OCI | — | — | — | — | — | — | — | $9.3t | $2.3t | $1.0t | |
| Placement of debt instruments in issue | — | — | — | — | — | — | — | $1.8t | $4.2t | $2.5t | |
| Payment of debt instruments in issue | — | — | — | — | — | — | — | ($3.9t) | ($9.3t) | ($1.6t) | |
| Dividends | — | — | — | — | — | — | — | ($127.4b) | ($140.6b) | ($154.4b) | |
| Dividend received | — | — | — | — | — | — | — | $155.7b | $223.3b | $237.3b | |
| Dividends paid | — | — | — | — | ($2.0b) | — | — | ($3.3t) | ($3.4t) | ($5.2t) | |
| Net cash (used) provided in financing activities(4) | $898.1m | ($374.3m) | ($2.6b) | ($211.1m) | ($2.1b) | ($161.9m) | $2.2b | ($5.4t) | ($9.2t) | ($8.2t) | |
| Effect of exchange rate changes | — | — | — | — | — | — | — | ($245.9b) | $307.7b | ($1.1t) | |
| Effect of exchange rate changes on cash and cash equivalents | $151.1m | ($24.6m) | $21.3m | ($265.8m) | ($434.2m) | $186.8m | ($630.2m) | ($5.4t) | $2.4t | ($1.2t) | |
| Increase / (decrease) in cash and cash equivalents | $1.2b | ($308.3m) | ($237.7m) | $725.0m | $715.5m | $7.2b | $7.0b | $13.6t | ($9.4t) | $1.8t | |
| Cash and cash equivalents at beginning of year | — | — | — | — | — | — | $31.6t | $39.8t | $32.8t | $33.4t | |
| Cash and cash equivalents at end of year | $7.5b | $7.5b | $7.0b | $7.0b | $7.7b | $15.1b | $21.5b | $23.6b | $29.2b | — | |
| Interest paid | — | — | — | — | — | — | — | ($16.0t) | ($15.0t) | ($13.3t) | |
| Income tax paid | — | — | — | ($4.2b) | ($1.7b) | ($31.2m) | ($204.5m) | ($2.7t) | ($2.0t) | ($2.4t) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.